Application of POCUS in patients with COVID-19 for acute respiratory distress syndrome management: a narrative review

COVID-19 has inflicted the world for over two years. The recent mutant virus strains pose greater challenges to disease prevention and treatment. COVID-19 can cause acute respiratory distress syndrome (ARDS) and extrapulmonary injury. Dynamic monitoring of each patient's condition is necessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xuehui, Zou, Xiaojing, Li, Ruiting, Shu, Huaqing, Yu, Yuan, Yang, Xiaobo, Shang, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817642/
https://www.ncbi.nlm.nih.gov/pubmed/35123448
http://dx.doi.org/10.1186/s12890-022-01841-2
Descripción
Sumario:COVID-19 has inflicted the world for over two years. The recent mutant virus strains pose greater challenges to disease prevention and treatment. COVID-19 can cause acute respiratory distress syndrome (ARDS) and extrapulmonary injury. Dynamic monitoring of each patient's condition is necessary to timely tailor treatments, improve prognosis and reduce mortality. Point-of-care ultrasound (POCUS) is broadly used in patients with ARDS. POCUS is recommended to be performed regularly in COVID-19 patients for respiratory failure management. In this review, we summarized the ultrasound characteristics of COVID-19 patients, mainly focusing on lung ultrasound and echocardiography. Furthermore, we also provided the experience of using POCUS to manage COVID-19-related ARDS.

Ejemplares similares